<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Curcumin (CUR) has anti-carcinogenic potential and has been complexed with β-CD in order to improve its bioavailability for cancer chemoprevention. In vivo studies were performed using rats injected with lung cancer cells, with a curcumin dose of 100 mg/kg. The curcumin-β-CD complex enhanced curcumin delivery and improved therapeutic efficacy compared to free curcumin in vivo and in vitro [
 <xref rid="B43-ijms-20-00642" ref-type="bibr" class="xref">43</xref>].
</p>
